text_1: In patients with congenital heart defects, β-blockers significantly improve clinical heart failure outcomes.
text_2: DESIGN, SETTING, AND PARTICIPANTS A multicenter, randomized, double-blind, placebo-controlled study of 161 children and adolescents with symptomatic systolic heart failure from 26 US centers.